Home

Differential
Counter

Flow
Tutorial

 

 
 
Myeloproliferative
neoplasms
Neoplasms with eosinophilia
(PDGRA/PDGFRB/FGFR1)
MDS/MPN MDS AML Acute leukemia
ambiguous lineage
Precursor lymphoid
neoplasms
Mature B cell
neoplasms
Mature T and NK
neoplasms
Hodgkin
lymphoma
Immunodeficiency associated
lymphoproliferative disorders
Histiocytic and dendritic
cell neoplasms
 

Chronic Myelogenous Leukemia

  Unusual antigen expression abstracts Prognostic abstracts Cytogenetic abstracts Antigen chart
Chronic myelogenous leukemia
Chronic neutrophilic leukemia
Polycythemia vera
Primary myelofibrosis
Essential thrombocythemia
Chronic eosinophilic leukemia, NOS
Mastocytosis
Myeloproliferative neoplasm, unclassifiable
Article Notes

Heterogeneous prognostic impact of derivative chromosome 9 deletions in chronic myelogenous leukemia.

Poor prognosis only if deletion spans the breakpoint, but not significant when censored for transplant or imatinib